Skip to main content
. 2017 Jul 20;6(4):456–471. doi: 10.1002/open.201700065

Figure 5.

Figure 5

Plasma‐clearance curves of ABZWCY–HPβCD: a) in the absence and b) in the presence of probenecid treatment by transcutaneous measurements in healthy rats. Plasma clearance curves of AAZWCY–HPβCD: c) in the absence of any treatment, d) in the presence of probenecid, and e) in the presence of cimetidine by transcutaneous measurements in healthy rats. f) Clearance half‐lives of ABZWCY–HPβCD and AAZWCY–HPβCD in the absence and presence of probenecid or cimetidine treatment.35 Reprinted with permission from Ref. 35. Copyright (2017) Royal Society of Chemistry.